The Hadden lab has received grant support from the Program in Innovative Therapeutics for Connecticut’s Health to develop inhibitors of translesion synthesis
The Hadden lab has received grant support from the Program in Innovative Therapeutics for Connecticut’s Health to develop inhibitors of translesion synthesis